Where Healthcare Innovators and Influencers Converge to Drive Change and Progress
Telehealth and Medicine Today™ (TMT) is an open access e-journal published by Partners in Digital Health. Our goal is to assist healthcare decision makers in launching sustainable telehealth services within clinically integrated healthcare systems. To this end, TMT offers rapid, peer reviewed publication of research and commentaries related to innovations in digital information and telecommunications technologies in patient centered care. Emphasis focuses on, but is not limited to, advances in program implementation and outcomes as a result of process improvement, advanced econometrics, and synergies that foster earlier interventions and advance value-based healthcare for the 21st century and future healthcare challenges.
Hospitals and medical research centers; payers; healthcare providers; medical directors; health economists; biopharm, biotech, and device companies; IT/IS; researchers; innovators; academicians; and all others with an interest in digital health and telemedicine will find content relevant to their interests in TMT.
CRITERIA FOR PUBLICATION
TMT applies rigorous editorial and peer review overseen by a team of professional editors and independent editor experts in the field.
Within the scope of the journal, as noted above, manuscripts should represent:
- Originality and practicality in advancing telehealth and telemedicine
- Importance to research, practice, or change in the field
- Interest and relevance for those outside the audience
- Rigorous methodology, with conclusions justified by the evidence presented
- Adherence to the highest ethical standards
Article submission charge is $750, is being waived for the first 6 issues of TMT.
The TMT editors are not paid a fixed salary (in particular, their salary is not linked to the number of articles published in the journal). Editors are required to declare all relevant competing interests and do not participate in the review of any submission for which they have a competing interest.
TMT applies the Creative Commons Attribution license to works we publish. This license was developed to facilitate open access.
In keeping with the goals of Creative Commons, TMT permits authors of articles published by TMT to legally share their articles to build a more equitable, accessible, and innovative world. Others who wish to use articles published by TMT in any way must give credit to TMT, but not in a way that suggests TMT endorses them or their use. If the latter applies they must get TMT’s permission first.
To submit a new manuscript, please send your submission to the Managing Editor, John Russo Jr., PharmD, firstname.lastname@example.org.
Peer review policy
All manuscripts submitted for publication undergo peer review. TMT‘s editorial team strives to ensure that peer review is fair, unbiased, timely. Material submitted to TMT remains confidential while under review.
Original research: These are detailed studies reporting original research in which telemedicine has played a significant role. They include hypothesis, background study, methods, results, interpretation of findings, and a discussion of possible implications. Original research articles have a word count of up to 2500.
Review article: Review articles give an overview of existing literature, with emphasis on telemedicine, often identifying specific problems or issues and analyzing information from available published work on the topic with a balanced perspective. Review articles can be of three types: literature reviews, systematic reviews, and meta-analyses. Review articles have the maximum word limit of up to 3000.
Clinical case study: Clinical case studies present the details of real patient cases from medical or clinical practice in which telemedicine played a significant role. The cases presented are usually those that contribute significantly to the existing knowledge on the field. The study is expected to discuss signs, symptoms, diagnosis, and treatment of a disease. The word count is up to 1500.
Clinical trial: Clinical trials describe the methodology, implementation, and results of controlled studies in which telemedicine played a significant role. Word count is 2500.
Perspective, opinion, interview, and commentary: These are scholarly reviews of fundamental concepts or prevalent ideas in a field of telemedicine. A perspective piece can be a review of a single concept or a few related concepts. These are around 1000 words.
Book review: The aim of a book review is to provide insight and opinion on recently published scholarly books on telemedicine or related topic. These are not more than 1000 word.
Departments for articles
- Research and Innovation
- New Technologies and Companies
- New Gamification and Behavior Modification Apps
- New Products and Devices
- Interviews and Opinions
- Training Tools for Health Professionals and Patients
- Policy and Regulation
- Global News
- Book Reviews
The Managing editor will assign the article to the relevant department.
Articles in TMT that offer continuing medical education credit (CME) have been designated in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Essential CME Inc. and Partners in Digital Health. Essential CME Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Essential CME Inc. designates CME-accredited articles for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
Articles published by TMT may contain information and discussions of published and/or investigational uses of devices and agents that are not indicated by the Food and Drug Administrations (FDA). Essential CME Inc. and Partners in Digital Health do not recommend the use of any devices or agents outside of the labeled indications.
Opinions expressed in articles designated for CME credit are those of the authors and do not necessarily represent the views of Essential CME Inc. or Partners in Digital Health.
Authorship and related information
Manuscripts should only be submitted for consideration once authorization of all contributing authors is gathered. The list of authors will include those who can legitimately claim authorship. This includes all those who:
- Have made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data
- Drafted the article or revised it critically for important intellectual content
- Approved the version to be published
Authors will meet the conditions of all of the points above. Each author will have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information.
The International Committee of Medical Journal Editors (ICMJE) has published the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (ICMJE Recommendations, formerly “Uniform Requirements for Manuscripts”). More information is here.
Authors will ensure the following guidelines are followed, as recommended by ICMJE, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is usually inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.
Ensure that the methodology has been accurately described for statistical analysis. In comparative studies power calculations are usually required. In research manuscripts requiring complex statistics the advice of an expert statistician should be sought at the design/implementation stage of the study. It may be appropriate to include them as a co-author.
If preparing statistical data for publication, please read the statistical guidelines.
Corresponding author contact details
Provide full contact details for the corresponding author including email, mailing address, and telephone numbers. Academic affiliations are required for all authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
Proofs and Reprints
PDF proofs will be sent to the corresponding author, who should send corrections as soon as the PDF is received. These corrections should be returned to the Managing Editor, John Russo Jr., PharmD, email@example.com.
Order forms for reprints will be emailed to the corresponding author shortly before publication of the article.
Submitted manuscripts should be exclusive publication in the TMT, with the understanding they have not been published elsewhere in any form and will not be submitted elsewhere unless rejected by the TMT. Authors are responsible for all statements made in the article and the veracity of the references cited.
Editorial and Peer Review Process
Authors can check the status of a manuscript at any time in the submission system. Authors will be notified by email when a decision is made.
Criteria for Publication
Within the scope of the journal, manuscripts should represent a substantial advance in medical science or medical practice in terms of:
- Originality and novelty
- Importance to researchers or practitioners in the field
- Interest in advancing value based medicine
- Rigorous methodology with conclusions justified by the evidence presented
- Adherence to the highest ethical standards
TMT aims to provide all authors with an efficient, courteous, and constructive editorial process. To achieve its required level of quality, TMT is selective with manuscripts that it publishes and anticipates rejection rates to be high, particularly since TMT has a provisional CME accreditation.
It is essential that authors submit a presubmission inquiry before submitting a full manuscript. Presubmission inquiries allow authors to quickly find out whether their manuscript is likely to be broadly suitable for TMT.
Responses are normally provided within 3 calendar days.
All articles, with the exception of editorials appearing in departments, are externally peer reviewed before a final decision about acceptance for publication. Expert reviewers are asked to assess the technical and scientific merits of the work. Where relevant, work presented in a manuscript undergoes a rigorous review of the statistical methods used.
As part of the review process, TMT strives to ensure that the peer review is fair, unbiased and timely. All manuscripts and associated material submitted to TMT remain confidential while under review. More information on related COPE (Committee on Publication Ethics) guidelines and standards followed by TMT are here.
How are reviewers selected?
TMT selects reviewers for a particular manuscript based on expertise, reputation, and specific recommendations of authors, as well as the TMT editorial board’s knowledge of a reviewer.
Will authors know who is reviewing their manuscript?
Reviewers’ identities are anonymous unless a reviewer indicates otherwise.
Can authors exclude Editorial Board Reviewers or Independent Reviewers?
Upon submission of a manuscript, authors are asked if they wish to exclude any specific reviewers from the peer review of their article. The editorial team respects these requests when it does not interfere with the objective and thorough assessment of the article.
Once all reviews are received and considered, a decision letter to the author is drafted.
Several types of decisions are possible. If after peer review a manuscript is considered potentially appropriate, a major revision is generally requested. A minor revision is generally requested as a final step before acceptance.
Manuscripts that are rejected generally do not fit the criteria outlined above in terms of originality, importance to the field, cross-disciplinary interest, or sound methodology.
Our Managing Editor and Primary Reviewer will assess revised manuscripts. Manuscripts that undergo major revision may require re-review or additional statistical review. There is no guarantee of acceptance after major revision.
If you wish to appeal a decision contact the Managing Editor who handled the presubmission inquiry or full manuscript, explaining in detail your reasons for the appeal.
All appeals are discussed with at least one other reviewer and editorial board member. In the case of disagreement the appeal is discussed during a full editorial meeting. TMT may seek external advice on the appeal at its option. Second appeals are not considered.
Process for Handling Allegations of Research Misconduct
TMT take reasonable steps to identify and prevent the publication of papers where research misconduct has occurred, including plagiarism, citation manipulation, and data falsification/fabrication, among others. TMT encourages meeting the highest ethical standards and publication practices are adhered to. In the event we are made aware of any allegation of research misconduct relating to a published article in their journal, we will follow COPE’s guidelines (or equivalent) in dealing with allegations.
If your manuscript has been accepted, TMT will send details and expected publish date along with all other relevant details.
If you have questions at any stage in the process, please email our Managing Editor, John Russo Jr., PharmD, firstname.lastname@example.org
It is essential that authors submit a presubmission inquiry before submitting a full manuscript. Presubmission inquiries allow authors to quickly learn whether their manuscript is likely to be suitable.
For other article types submit a short summary paragraph or bullet points.
- This section should describe clearly the rationale for the study. The final sentence should state the specific study hypothesis and/or study objectives.
- Describe the study participants or what was studied (e.g., patient population, cell lines; be as specific as possible, including numbers studied).
- Describe the study design, intervention if applicable, main methods used, primary outcome measure(s), and length of follow up if applicable.
- Describe what was primarily being assessed (e.g. primary outcome measure and, if appropriate, over what period).
- Describe how results were analyzed (i.e., which specific statistical tests were used).
- Include how many participants were assessed out of those enrolled. For survey research, include the response rate.
- For the main outcomes provide a numerical result if appropriate (it nearly always is) and a measure of its precision (e.g. 95% confidence interval).
- Describe all adverse events.
- Describe the limitations of the study.
- Integrate these findings into the current state of knowledge
- Provide a general interpretation of the results with any implications supported by the research and important recommendations for future research.
For a clinical trial provide trial identification numbers and names (e.g., trial registration number, protocol number or acronym).
MULTIMEDIA, FIGURES, AND TABLES
General Guidelines for Illustrations
Image Manipulation: Authors must retain their unprocessed data and metadata files, as editors may request them to aid in manuscript evaluation. If unprocessed data are unavailable, manuscript evaluation may be halted until the issue is resolved. If the original data cannot be produced, the manuscript may be rejected.
Use of Color: Illustrations must be prepared so that they are accessible to our many color-blind readers. The following sites contain useful information, tips and tools on appropriate use of color in illustrations:
Multimedia and 3D Models
TMT publishes multimedia and 3D models embedded in the HTML and PDF versions of articles. Essential multimedia and models will be displayed in line with the article text, as is done for figures.
Multimedia and 3D models are be accepted only when needed to display findings that 1) are essential to defend the articles conclusions and 2) could not be presented adequately in the text, a table, or a figure. The editors will review all multimedia and 3D models to determine whether they are essential. It is unlikely that more than one or two multimedia files that illustrate representative examples will be considered justified.
Multimedia and 3D models must be numbered independently of figures and tables, and cited at the relevant point in the manuscript text, e.g., “Movie 1”, “Movie 2”, and “Model 1”, “Model 2”.
A title should be part of the legend and not lettered onto the multimedia or 3D model itself.
A legend must be included in the manuscript document after the reference list and not included in the video or 3D model itself. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information. If videos are not in real time and the time is not displayed in the video, the period represented must be stated in the legend. Rather than stating “See text,” legends should be more specific; for example, “See Results”.
Videos and 3D models should be the smallest size that will convey the essential scientific information.
Multimedia files must be in MP4 format, and should not be larger than one megabyte. 3D models must be in U3D format.
To optimize videos for PC, tablet and smartphone viewing, format videos with the following specifications:
- Video codec: H.264
- Audio codec: AAC
- Audio bit rate: 128 kbit/s
- Video resolution: 480 vertical lines or better
- Size: Maximum width of 480 pixels
To convert videos from other formats to MP4 format, the following resource is available: http://download.cnet.com/Free-MP4-Video-Converter/3000-2194_4-75628166.html.
For each video submitted, authors should provide a preview image, or poster frame, that best captures the main point.
Figures must be numbered independently of tables, multimedia, and 3D models and cited at the relevant point in the manuscript text, e.g. “Figure 1”, “Figure 2”, etc. Do not duplicate data by presenting it both in the text and in a figure.
A title should be part of the legend and not lettered onto the figure.
A legend must be included in the manuscript document after the reference list. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information. Rather than stating “See text,” legends should be more specific; for example, “See Results”.
Figures should be the smallest size that will convey the essential scientific information.
Initial Submission: Figures may be included in a single PDF file that contains the manuscript and all tables and figures.
Revised Submission or Resubmission: Figures must be submitted only as separate files in TIFF or EPS format. Note: EPS images cannot use the Adobe_CoolType_Utility. This is not compatible with the current image processing guidelines used by the TMT online hosting provider.
Color figures should be in RGB format and supplied at a minimum of 300 dpi. Color is essential in a figure if it is necessary to accurately convey the information being presented by the image. Non-essential color refers to figures in which the color is not necessary for the meaning of the image to be made clear. Color should only be used in figures when essential.
For figures in vector-based format, all fonts should be converted to outlines and saved as EPS (Encapsulated PostScript) to ensure that they are reproduced correctly.
- Monochrome (bitmap) images must be supplied at 1200 dpi.
- Grayscale must be supplied at a minimum of 300 dpi.
Remove top and right borderlines (that to not contain measuring metrics) from all graph/histogram figure panels (do not box the panels in).
Do not include any two-bar graphs/histograms. State those values in the text. Two-bar graphs/histograms are generally discouraged because the result can be conveyed more precisely and compactly numerically.
Ensure that figures will appear at the highest quality. Review the detailed instructions for figure preparation at http://cpc.cadmus.com/da/index.jsp. To better assist authors with digital art preparation, TMT has made available Cadmus’ Rapid Inspector application, which alerts users when files do not meet acceptable specifications and provides instructions on reformatting. Sign up at the Rapid Inspector web site: http://rapidInspector.cadmus.com/RapidInspector/zo5/index.jsp to download the application. Problems downloading the application can be addressed at the FAQs at the Cadmus site.
All tables must be numbered independently of figures, multimedia and 3D models and cited at the relevant point in the manuscript text, e.g. “Table 1”, “Table 2”, etc. Do not duplicate data by presenting it both in the text and in a table.
A title should appear above the table.
A legend for each table must be included in the manuscript document after the reference list. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information. Rather than stating “See text,” legends should be more specific; for example, “See Results.”
Each table should be double-spaced. Multiple-part tables (A and B sections with separate “subtitles”) should be avoided when possible, especially when there are two [different] sets [or types] of column headings.
Do not use color or shading, bold or italic fonts, or lines to highlight information. Indention of text and, sometimes, additional space between lines is preferred.
Tables with color or shading in the table body will need to be processed as an illustration (graphic).
Scholarly medical research journals online
TMT is a leading international peer-reviewed journal.
We cover a wide range of topics in telemedicine and e-health. We take pride in catering to an extensive audience, including hospitals, medical research centers, healthcare providers, biopharm, biotech, device companies and more.
TMT is suitable for all those with an interest in digital health and telemedicine industry. Browse through our website to find original, peer reviewed articles and interviews and more.
Explore our telehealth journal and learn more about how to submit an article.